AI Insight
This is the third paper in a Lancet series on peripheral arterial disease (PAD), a condition affecting over 300 million people globally. While previous papers covered diagnosis through non-invasive testing and treatment approaches including medication, exercise therapy, and revascularization, this paper focuses on the severe individual-level consequences of PAD. These impacts include chronic pain, functional limitations, loss of independence, diminished physical and mental quality of life, unemployment, and financial instability.
Why it matters
Understanding the full scope of PAD's impact beyond clinical symptoms is essential for comprehensive patient care and public health planning. The documented effects on employment, independence, and quality of life highlight the need for integrated treatment approaches that address both medical and socioeconomic dimensions of the disease.
Understand the Science
This is the third paper in the peripheral arterial disease (PAD) Series. The first and second papers in this Series outline that PAD affects over 300 million people worldwide and can be diagnosed by non-invasive tests, as well as that treatment requires medications to reduce modifiable risk factors and that exercise therapy and revascularisation are required in selected patients. In this paper, the devastating effects of PAD at the individual level are described, including chronic pain, functional limitation, loss of independence, impaired physical and mental quality of life, unemployment, and financial instability.
Source: [Series] Peripheral arterial disease: adverse impacts, disparities in outcomes, and the path ahead